Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens

Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens

Systemic sclerosis (SSc)-related Raynaud’s phenomenon (RP) and digital ulcers (DU) can impair health-related quality of life (HRQoL). The aim of our study was to estimate HRQoL in SSc patients treated with two different intravenous (IV) iloprost (ILO) regimens and in patients not treated with IV IL...

Full description

Bibliographic Details
Main Authors:	T. Schioppo, L. Scalone, P. Cozzolino, L. Mantovani, G. Cesana, O. De Lucia, A. Murgo, F. Ingegnoli
Format:	Article
Language:	English
Published:	PAGEPress Publications 2019-07-01
Series:	Reumatismo
Subjects:	Iloprost prostacyclin systemic sclerosis health related quality of life EQ-5D-5L
Online Access:	https://www.reumatismo.org/index.php/reuma/article/view/1190

Similar Items

Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center
by: A. Di Vita, et al.
Published: (2012-07-01)

Iloprost Attenuates Oxidative Stress-Dependent Activation of Collagen Synthesis Induced by Sera from Scleroderma Patients in Human Pulmonary Microvascular Endothelial Cells
by: Roberta Giordo, et al.
Published: (2021-08-01)

Intravenous prostacyclin analogue iloprost (Ilomedin®) in the treatment of a patient with Buerger’s disease
by: Ilshat Ravilevich Gaisin, et al.
Published: (2013-03-01)

The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial
by: Matthieu Legrand, et al.
Published: (2020-07-01)

Effect of cyclic intravenous Iloprost therapy in patients with Idiopathic Pulmonary Artery Hypertension
by: Majid MalekMohammad, et al.
Published: (2017-02-01)

Treating a Patient with Bone Marrow Edema Syndrome with Iloprost
by: mojtaba piri, et al.
Published: (2015-08-01)

Iloprost infusion through elastomeric pump for the outpatient treatment of severe Raynaud’s phenomenon and digital ulcers – a single centre experience
by: Ana Catarina Duarte, et al.
Published: (2018-07-01)

Inhaled iloprost for the treatment of patient with Fontan circulation
by: Yong Hyun Kim, et al.
Published: (2014-10-01)

Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension
by: I N Zavyrylina, et al.
Published: (2015-06-01)

Iloprost in COVID-19: The Rationale of Therapeutic Benefit
by: Paola Maria Faggioli, et al.
Published: (2021-04-01)

Proposal of early retreatment with iloprost in partially responsive patients with bone marrow edema syndrome: a case report
by: Simone Meini, et al.
Published: (2012-12-01)

Intravenous iloprost in the combination therapy of vascular disorders in patients with systemic connective tissue diseases
by: Aleksandr Vitalyevich Volkov, et al.
Published: (2013-06-01)

Inhaled iloprost for the treatment of pulmonary hypertension
by: H. Olschewski
Published: (2009-03-01)

Infusion of iloprost without a peristaltic pump: Safety and tolerability
by: Paola Faggioli, et al.
Published: (2013-04-01)

Inhaled iloprost as part of combination therapy for persistent pulmonary hypertension of the newborn
by: Heru Samudro, et al.
Published: (2012-03-01)

Iloprost infusion by a new device as a portable syringe pump: safety, tolerability and agreement
by: Paola Faggioli, et al.
Published: (2012-12-01)

COVID-19 acute respiratory distress syndrome: can iloprost have a role for the treatment?
by: Alida Filippini, et al.
Published: (2021-01-01)

Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension
by: Wang L, et al.
Published: (2017-11-01)

Iloprost for acute tests in patients with pulmonary arterial hypertension
by: E A Belyatko, et al.
Published: (2012-12-01)

Long-term clinical results after iloprost treatment for bone marrow edema and avascular necrosis
by: Tim Claßen, et al.
Published: (2016-03-01)

Protective effects of hyperbaric oxygen and iloprost on ischemia/reperfusion-induced lung injury in a rabbit model
by: Bozok Ş, et al.
Published: (2012-06-01)

Iloprost Pretreatment Before Unilateral Nephrectomy: An Experimental Study in Rats
by: Erman Aytac, et al.
Published: (2008-04-01)

COMPARISON OF HEMODYNAMIC EFFECTS OF INHALATORY ILOPROST AND NITRIC OXIDE IN PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION
by: A. E. Bautin, et al.
Published: (2017-12-01)

Bone marrow aspirate concentrate in combination with intravenous iloprost increases bone healing in patients with avascular necrosis of the femoral head: a matched pair analysis
by: Hakan Pilge, et al.
Published: (2017-01-01)

Beneficial Effects of Iloprost on Acute Myocardial Ischemia in Dogs
by: SAKAMOTO, NOBUO, et al.
Published: (1994)

Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study
by: Helene Haeberle, et al.
Published: (2020-03-01)

Adverse Events of Prostacyclin Mimetics in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
by: Christina Picken, et al.
Published: (2019-04-01)

The Effects of Iloprost on Oxygenation During One-Lung Ventilation for Lung Surgery: A Randomized Controlled Trial
by: Hoon Choi, et al.
Published: (2019-07-01)

Inhaled iloprost induces long-term beneficial hemodynamic changes in patients with pulmonary arterial hypertension receiving combination therapy
by: Adachi, S., et al.
Published: (2022)

Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts
by: Maurizio Cutolo, et al.
Published: (2018-05-01)

Evaluation of compliance of pulmonary hypertension patients to the treatment with inhaled iloprost (Ventavis): results of prospective, multicenter, non-interventional IVENT study
by: Tamila V Martynyuk
Published: (2019-06-01)

Iloprost, a prostacyclin (PGI2) analogue, reduces liver injury in hepatic ischemiareperfusion in rats Iloprost, um análogo da prostaciclina (PGI2), reduz danos da isquemia/reperfusão hepática em ratos
by: Ercan Gedik, et al.
Published: (2009-06-01)

Nitroglycerin and Iloprost Improve Mitochondrial Function in Colon Homogenate Without Altering the Barrier Integrity of Caco-2 Monolayers
by: Anna Herminghaus, et al.
Published: (2018-10-01)

Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)—a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy
by: Rasmus Ehrenfried Berthelsen, et al.
Published: (2019-09-01)

Acute Response of Right Ventricular Function to Iloprost Inhalations in Patients with Pulmonary Arterial Hypertension: Preliminary Evaluation  with Cardiac Magnetic Resonance Imaging
by: Qingqing LU, et al.
Published: (2015-03-01)

Pulpal Response to the Combined Use of Mineral Trioxide Aggregate and Iloprost for Direct Pulp Capping
by: AlAnoud Almeshari, et al.
Published: (2021-04-01)

Effects of alprostadil and iloprost on renal, lung, and skeletal muscle injury following hindlimb ischemia–reperfusion injury in rats
by: Erer D, et al.
Published: (2016-08-01)

Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome
by: Natalia A. Tsareva, et al.
Published: (2021-07-01)

Acute Iloprost Inhalation Improves Right Ventricle Function in Pulmonary Artery Hypertension: A Cardiac Magnetic Resonance Study
by: Jing-Hui Li, et al.
Published: (2019-01-01)

Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
by: Julia Timofeev, et al.
Published: (2013-03-01)